Endocrine System Diseases

"Endocrine System Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.

Descriptor ID	D004700
MeSH Number(s)	C19
Concept/Terms	Endocrine System Diseases Endocrine System Diseases Disease, Endocrine System Diseases, Endocrine System Endocrine System Disease System Disease, Endocrine System Diseases, Endocrine Endocrine Diseases Disease, Endocrine Diseases, Endocrine Endocrine Disease Diseases of Endocrine System

Below are MeSH descriptors whose meaning is more general than "Endocrine System Diseases".

Diseases [C]
Endocrine System Diseases [C19]

Below are MeSH descriptors whose meaning is more specific than "Endocrine System Diseases".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Endocrine System Diseases" by people in this website by year, and whether "Endocrine System Diseases" was a major or minor topic of these publications.

Bar chart showing 13 publications over 9 distinct years, with a maximum of 3 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
2001	1	0	1
2005	0	1	1
2008	2	0	2
2009	1	1	2
2011	0	1	1
2013	1	0	1
2014	1	0	1
2015	3	0	3

Below are the most recent publications written about "Endocrine System Diseases" by people in Profiles.

Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Response to the Letter by Middlebeek and Veuger. J Clin Endocrinol Metab. 2015 Jun; 100(6):L54-5.

View in: PubMed
Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015 Apr; 100(4):1256-66.

View in: PubMed
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015 Apr; 100(4):1245-55.

View in: PubMed
Meyer JS, Hamel AF. Models of stress in nonhuman primates and their relevance for human psychopathology and endocrine dysfunction. ILAR J. 2014; 55(2):347-60.

View in: PubMed
Frank GR, Fox J, Candela N, Jovanovic Z, Bochukova E, Levine J, Papenhausen PR, O'Rahilly S, Farooqi IS. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):191-4.

View in: PubMed
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011 Sep 29; 118(13):3479-88.

View in: PubMed
Daouk GH, Ingelfinger JR. Recent advances in the pathogenesis of hypertension in children. J Med Liban. 2010 Jul-Sep; 58(3):137-41.

View in: PubMed
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009 Jun; 30(4):293-342.

View in: PubMed
Lahiry P, Wang J, Robinson JF, Turowec JP, Litchfield DW, Lanktree MB, Gloor GB, Puffenberger EG, Strauss KA, Martens MB, Ramsay DA, Rupar CA, Siu V, Hegele RA. A multiplex human syndrome implicates a key role for intestinal cell kinase in development of central nervous, skeletal, and endocrine systems. Am J Hum Genet. 2009 Feb; 84(2):134-47.

View in: PubMed
Ndumele CD, Russell BE, Ayanian JZ, Landon BE, Keegan T, O'Malley AJ, Hicks LS. Strategies to improve chronic disease management in seven metro Boston community health centers. Prog Community Health Partnersh. 2009; 3(3):203-11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals